Thai FDA Electronic Systems: e-Submission, SKYNET and NSW Explained

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Thai registration work runs across three electronic systems, each with a distinct role. Product registration filings go through the Thai FDA e-Submission system. Renewals of establishment licences and registration certificates are handled uniformly in the SKYNET system, which since July 2025 has been the single channel for all certificate renewals. Imports run through the National Single Window (NSW), which is used to apply for an LPI, the per-shipment import licence. Knowing which system owns which transaction prevents the most common operational failures in the Thai market. None of the three systems is optional, and none of them substitutes for another: a product can be perfectly registered and still be un-importable if the licence renewal or the per-shipment licence is missing.

SystemPurposeTiming
e-SubmissionProduct registration filings (Class 1 listing / Class 2-4 notification and licensing)First filings, changes, transfers
SKYNETRenewal of establishment licences and registration certificatesAnnual window 1 October to 31 December
NSWLPI per-shipment import licenceBefore each shipment is imported
  • The first step inside e-Submission is a completeness check of roughly 15 days; incomplete dossiers are stopped within those 15 days rather than discovered months later.
  • The SKYNET renewal window is a hard constraint: 1 October to 31 December, filed in the year the certificate expires. Missing it means the registration lapses and SKYNET closes the import customs channel for that entry.
  • Remediation after expiry is possible within 1 month, until 31 January of the following year, with an explanation and a daily penalty of approximately 500 to 1,000 baht per day depending on category.
  • The LPI is applied for online by the licence-holding importer, bound to the invoice, one application per shipment, with review of roughly 1 to 2 working days; without an LPI, customs will not release the goods.

2. Legal basis

The system architecture is published by the Thai FDA: e-Submission for product filings, SKYNET for the unified renewal regime in operation since July 2025, and the NSW for import licensing, with post-market obligations described at Step 6 of the For Commercial Purpose process. Within e-Submission, the completeness check runs approximately 15 days before substantive review begins, so documentation gaps surface early. Within SKYNET, the renewal window runs from 1 October to 31 December in the expiry year; if missed, the registration becomes invalid and the system closes the import customs channel for the certificate entry, blocking clearance. A remediation window of 1 month after expiry, until 31 January of the following year, allows late renewal with a stated reason and a daily penalty of approximately 500 to 1,000 baht per day depending on the category. On the import side, the LPI application is made by the licence-holding importer, is bound to the commercial invoice with one application per shipment, and requires the importer establishment licence, valid product registration certificates and original shipping documents including the bill of lading, commercial invoice and packing list. The Thai FDA checks every model listed on the invoice, including accessories and spare parts, against the valid registration scope, and the review takes approximately 1 to 2 working days. The consequence is stated bluntly by the system itself: no LPI, no customs release.

3. Expert insights

The most frequent operational accidents in Thailand fall into three patterns. First, the missed renewal window: teams treat renewal as something to handle after a certificate expires, and discover that the import channel has been closed and goods are stuck. Second, the late LPI: the application is filed only after the goods arrive at port, generating demurrage and storage charges that a 1 to 2 working day review could have avoided. Third, the mixed shipment: a single invoice combining products whose certificates have expired with products that are valid usually cannot be partially cleared, so the whole shipment is blocked by its weakest line item. Partial clearance is generally not permitted, which turns one expired model into a warehouse problem for an entire order. A practical estimate of the underlying cause is that none of these failures involves regulatory judgment at all; all three are calendar failures, which is why they are also the cheapest failures to prevent. The SKYNET renewal window in particular is a fixed task, independent of whether anything has gone wrong on the product side, and belongs on a calendar rather than in anyone’s memory, because the date is set by the authority and repeats every year whether or not anyone remembers it.

4. Practical recommendations

  • Build the key dates of all three systems into a company compliance calendar with double reminders, especially the SKYNET renewal window each October to December.
  • Start every LPI application before shipment departure, not on arrival, and check that the invoice lists only models covered by valid certificates, including accessories and spare parts.
  • Never mix expired and valid products on one invoice; split shipments so that a single expired line cannot block a whole consignment.
  • Track the completeness check of approximately 15 days as the first milestone after e-Submission filing, and use it to catch documentation gaps early.
  • If a renewal has already lapsed, act within the 1-month remediation window until 31 January, with a prepared explanation and budget for the daily penalty of approximately 500 to 1,000 baht per day.

5. Verification checklist

  • □ Thai FDA e-Submission system, completeness check of approximately 15 days (pending verification).
  • □ SKYNET renewal system, annual window 1 October to 31 December, import channel closed on lapse, 1-month remediation until 31 January (pending verification).
  • □ NSW National Single Window, LPI application with review of approximately 1 to 2 working days (pending verification).
  • □ Thai FDA website For Commercial Purpose Step 6, post-market obligations (pending verification).
  • □ Thai FDA announcement on the unified renewal system, effective since July 2025 (pending verification).

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Thailand. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the Thai FDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail